Silverback Therapeutics, Inc. (NASDAQ:SBTX – Get Free Report)’s share price rose 3.3% on Friday . The company traded as high as $11.60 and last traded at $11.32. Approximately 1,268,100 shares traded hands during trading, an increase of 275% from the average daily volume of 337,931 shares. The stock had previously closed at $10.96.
Silverback Therapeutics Price Performance
The company has a market capitalization of $408.18 million, a P/E ratio of -4.68 and a beta of 0.60. The company has a 50 day moving average of $14.25 and a 200-day moving average of $12.31.
Silverback Therapeutics Company Profile
Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.
Featured Articles
- Five stocks we like better than Silverback Therapeutics
- What Are the U.K. Market Holidays? How to Invest and Trade
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- Insider Trading – What You Need to Know
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- Retail Stocks Investing, Explained
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for Silverback Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silverback Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
